Patents by Inventor Ichiro Miki
Ichiro Miki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11916296Abstract: An antenna device, for a mobile body, of this disclosure includes an antenna configured to be installed in the mobile body, and a reflector having a reflection surface configured to change a beam direction of the antenna.Type: GrantFiled: January 29, 2020Date of Patent: February 27, 2024Assignees: AUTONETWORKS TECHNOLOGIES, LTD., SUMITOMO WIRING SYSTEMS, LTD., SUMITOMO ELECTRIC INDUSTRIES, LTD.Inventors: Yutaro Miki, Suguru Yamagishi, Takanori Fukunaga, Ichiro Kuwayama, Toyohisa Takano, Hiroki Hirai, Norichika Oomi, Kosuke Sone, Yasuyuki Yamamoto
-
Publication number: 20230103313Abstract: A user assistance system for handling software is provided with an excellent usability. A user assistance system includes acquisition means, selection means, and presentation means. The acquisition means acquires text data input from a user. The selection means refers to a selection model indicating a relation between a preliminarily acquired word group including one or more words and function information regarding a function of software, and selects the function information relative to a word group including one or more words included in the text data acquired by the acquisition means. The presentation means presents the function information selected by the selection means to the user.Type: ApplicationFiled: October 4, 2022Publication date: April 6, 2023Inventor: Ichiro MIKI
-
Patent number: 7708999Abstract: The invention provides an agent for preventing or treating arthritis, a cartilage protecting agent, a joint destruction inhibitor and a synovial membrane growth inhibitor comprising an anti-FGF-8 neutralizing antibody as an active ingredient, as well as a diagnostic agent of arthritis comprising an anti-FGF-8 antibody as an active ingredient and a method for judging arthritis using the antibody.Type: GrantFiled: December 26, 2002Date of Patent: May 4, 2010Assignee: Kyowa Hakko Kirin Co., Ltd.Inventors: Tadafumi Tamura, Masako Uchii, Toshio Suda, Ichiro Miki, Akira Tanaka
-
Patent number: 7691367Abstract: The present invention provides branched polyalkylene glycols useful as a chemically modifying agent for physiologically active polypeptides, wherein two single-chain polyalkylene glycols are linked to a group having a cyclic structure other than a plane structure, and wherein a group having reactivity with an amino acid side chain, an N-terminal amino group or a C-terminal carboxyl group in a polypeptide or a group convertible into the group having reactivity is linked to the group having a structure other than a plane structure.Type: GrantFiled: December 22, 2000Date of Patent: April 6, 2010Assignee: Kyowa Hakko Kirin Co., Ltd.Inventors: Motoo Yamasaki, Toshiyuki Suzuwa, Tatsuya Murakami, Noriko Sakurai, Kinya Yamashita, Mayumi Mukai, Takashi Kuwabara, So Ohta, Ichiro Miki
-
Patent number: 7524852Abstract: [wherein m and n may be the same or different and each represents an integer of 1 to 3 wherein m+n is 4 or less; R1 represents —NR4R5 (wherein R4 and R5 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl or the like); R2 represents the above Formula (II), Formula (IV) or the like; A represents a single bond, —C(?O)—, —SO2—, —OC(?O)— or the like; and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or the like] Bicyclic pyrimidine derivatives represented by the above Formula (I), or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof, or the like, are provided.Type: GrantFiled: June 6, 2003Date of Patent: April 28, 2009Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Hitoshi Arai, Tsutomu Matsumura, Hiroshi Ishida, Yosuke Yamaura, Seiji Aratake, Etsuo Ohshima, Koji Yanagawa, Motoki Miyama, Koji Suzuki, Ari Kawabe, Satoshi Nakanishi, Katsuya Kobayashi, Takashi Sato, Ichiro Miki, Kimihisa Ueno, Shinya Fujii, Miho Iwase
-
Publication number: 20070172447Abstract: The present invention relates to an agent for preventing and/or treating diseases accompanied by tissue disruption, which comprises a polypeptide having granulocyte colony-stimulating factor activity as an active ingredient, and a medicament for mobilizing a multipotent stem cell from a tissue into peripheral blood, which comprises a polypeptide having granulocyte colony-stimulating factor activity as an active ingredient.Type: ApplicationFiled: May 14, 2004Publication date: July 26, 2007Inventors: Kazuhiro Sakurada, Yoji Yamada, Hiroshi Ando, Hidetaka Sato, Hiromi Yokoyama, Masahiko Ishihara, Ichiro Miki, Akiko Watanabe
-
Publication number: 20070037834Abstract: [wherein m and n may be the same or different and each represents an integer of 1 to 3 wherein m+n is 4 or less; R1 represents —NR4R5 (wherein R4 and R5 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl or the like); R2 represents the above Formula (II), Formula (IV) or the like; A represents a single bond, —C(?O)—, —SO2—, —OC(?O)— or the like; and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or the like] Bicyclic pyrimidine derivatives represented by the above Formula (I), or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof, or the like, are provided.Type: ApplicationFiled: June 6, 2003Publication date: February 15, 2007Inventors: Hitoshi Arai, Tsutomu Matsumura, Hiroshi Ishida, Yosuke Yamaura, Seiji Aratake, Etsuo Ohshima, Koji Yanagawa, Motoki Miyama, Koji Suzuki, Ari Kawabe, Satoshi Nakanishi, Katsuya Kobayashi, Takashi Sato, Ichiro Miki, Kimihisa Ueno, Shinya Fujii, Miho Iwase
-
Publication number: 20060286040Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics of the formula 1; wherein X?, R1 ? and Ar are defined as in claim 1, and a heterocyclic compound of the formula 2. Furthermore, the invention relates to processes for preparing them and their use in the treatment of respiratory complaints.Type: ApplicationFiled: August 5, 2004Publication date: December 21, 2006Applicant: Kyowa Hakko Kogyo Co., Ltd.Inventors: Christopher Meade, Michel Pairet, Michael Pieper, Yuzuru Abe, Ichiro Miki
-
Publication number: 20060205756Abstract: An antitussive which comprises, as an active ingredient, a tricyclic compound represented by Formula (I) [wherein R1 represents a hydrogen atom, substituted or unsubstituted lower alkyl or the like, X1—X2—X3 represents CR5?CR6—CR7?CR8 (wherein R5, R6, R7 and R8 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl or the like, Y represents —CH2S— or the like, and R2 represents a hydrogen atom, substituted or unsubstituted lower alkyl or the like] or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: March 31, 2004Publication date: September 14, 2006Applicant: Kyowa Hakko Kogyo Co., Ltd.Inventors: Ichiro Miki, Hidee Ishii
-
Publication number: 20060205749Abstract: The present invention provides a therapeutic and/or preventive agent for pulmonary disease that exhibits neutrophilic inflammation, such as, chronic obstructive pulmonary disease (COPD), pulmonary emphysema, chronic bronchitis, acute respiratory distress syndrome (ARDS), acute lung injury (ALI) and the like, which comprises 7-[2-(3,5-dichloro-4-pyridyl)-1-oxoethyl]-4-methoxy-spiro[1,3-benzodioxol-2,1?-cyclopentane] or a pharmaceutically acceptable salt thereof as an active ingredient.Type: ApplicationFiled: March 31, 2004Publication date: September 14, 2006Inventors: Yuzuru Abe, Ichiro Miki
-
Publication number: 20060194811Abstract: A pyrimidine derivative represented by Formula (I) wherein Ar represents substituted or unsubstituted aryl, R1 represents —NR2R3 and wherein R2 represents a hydrogen atom or substituted or unsubstituted lower alkyl and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, A represents a single bond, Formula (III) wherein m1 is 0 to 2, n1 is 0 to 4, a1 is from 0 to a substitutable number, R5 represents substituted or unsubstituted lower alkyl, and each R5 may be the same or different when a1 is 2 or more), and Q represents —NR6R7 (wherein R6 and R7 may be the same or different and each represents a hydrogen atom, a substituted or unsubstituted heteroalicyclic group, a substituted or unsubstituted heteroalicyclic group, substituted or unsubstituted piperidin-4-ylamino, or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof.Type: ApplicationFiled: February 20, 2004Publication date: August 31, 2006Applicant: KYOWA HAKKO KOGYO CO., LTD.Inventors: Etsuo Ohshima, Motoki Miyama, Koji Yanagawa, Seiji Aratake, Ichiro Miki, Katsuya Kobayashi
-
Publication number: 20050175608Abstract: The invention provides an agent for preventing or treating arthritis, a cartilage protecting agent, a joint destruction inhibitor and a synovial membrane growth inhibitor comprising an anti-FGF-8 neutralizing antibody as an active ingredient, as well as a diagnostic agent of arthritis comprising an anti-FGF-8 antibody as an active ingredient and a method for judging arthritis using the antibody.Type: ApplicationFiled: December 26, 2002Publication date: August 11, 2005Inventors: Tadafumi Tamura, Masako Uchii, Toshio Suda, Ichiro Miki, Akira Tanaka
-
Publication number: 20040175825Abstract: The present invention relates to a monoclonal antibody which specifically reacts with natural MT4-MMP or solubilized MT4-MMP. Also, the present invention provides a monoclonal antibody which specifically and efficiently recognizes a natural MT4-MMP catalytic domain; a human chimeric antibody, a CDR-grafted antibody, a single chain antibody and a disulfide stabilized antibody, comprising the same; and a method for detecting and determining MT4-MMP protein using the antibodies. Furthermore, the present invention provides a diagnostic method, a diagnostic agent and a therapeutic agent for various diseases relating to MP4-MMP such as inflammation and cancer, using the antibodies.Type: ApplicationFiled: December 11, 2003Publication date: September 9, 2004Inventors: Ichiro Miki, So Ohta, Kenya Shitara, Akiko Furuya
-
Publication number: 20040161478Abstract: The present invention relates to an agent for preventing or treating arthritis which comprises as an active ingredient a plant belonging to the family Saxifragaceae or its extract, foods and drinks or feeds comprising a plant belonging to the family Saxifragaceae or its extract, a method for preventing or treating arthritis in animals which comprises giving animals an agent or a feed for preventing or treating arthritis, and a food and drink or feed for preventing or treating arthritis which comprises as an active ingredient a plant belonging to the family Saxifragaceae or its extract.Type: ApplicationFiled: December 9, 2003Publication date: August 19, 2004Inventors: Rysuke Nakagiri, Toshikazu Kamiya, Toshio Suda, Ichiro Miki
-
Publication number: 20030219404Abstract: The present invention provides branched polyalkylene glycols useful as a chemically modifying agent for physiologically active polypeptides, wherein two single-chain polyalkylene glycols are linked to a group having a cyclic structure other than a plane structure, and wherein a group having reactivity with an amino acid side chain, an N-terminal amino group or a C-terminal carboxyl group in a polypeptide or a group convertible into the group having reactivity is linked to the group having a structure other than a plane structure.Type: ApplicationFiled: June 24, 2002Publication date: November 27, 2003Inventors: Motoo Yamasaki, Toshiyuki Suzawa, Tatsuya Murakami, Noriko Sakurai, Kinya Yamashita, Mayumi Mukai, Takashi Kuwabara, So Ohta, Ichiro Miki
-
Publication number: 20030100772Abstract: The present invention relates to oxygen-containing heterocyclic compounds represented by the following formula (I): 1Type: ApplicationFiled: August 28, 2002Publication date: May 29, 2003Inventors: Etsuo Ohshima, Koji Yanagawa, Haruhiko Manabe, Ichiro Miki, Yoshiaki Masuda
-
Publication number: 20030064599Abstract: In the production of semiconductor devices, when forming a predetermined pattern within a to-be-processed material such as interlayer film, photoresist is first applied over the material, then exposed, and developed, to thereby form a resist film having the predetermined pattern shape on the material. The material is next etched to a predetermined depth through the resist film as a mask. The resist film is removed and then the material is further etched to form the predetermined pattern within the material. Then, an etching stopper film has been formed at a predetermined depth, the etching is continued until the etching reaches the etching stopper film, and then the photoresist is removed. Additionally, an antireflection layer is used as the etching stopper film.Type: ApplicationFiled: August 9, 2002Publication date: April 3, 2003Inventors: Ichiro Miki, Takeshi Matsunuma, Kiyoshi Maeda
-
Patent number: 6376535Abstract: The present invention relates to oxygen-containing heterocyclic compounds represented by the following formula (I): wherein m represents an integer of 0 to 4; R1, R2, R3 and R4 independently represent a hydrogen atom, substituted or unsubstituted lower alkyl, etc.; R5 represents substituted or unsubstituted lower alkoxy etc.; R6 represents a hydrogen atom etc.; and Y represents the following formula (II): wherein R9 represents cyano etc., R10 represents a hydrogen atom etc., R11 represents carboxy etc., and R12 represents a hydrogen atom etc.; and the like; or pharmaceutically acceptable salts thereof.Type: GrantFiled: March 1, 2001Date of Patent: April 23, 2002Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Etsuo Ohshima, Koji Yanagawa, Haruhiko Manabe, Ichiro Miki, Yoshiaki Masuda
-
Publication number: 20010056117Abstract: The present invention relates to oxygen-containing heterocyclic compounds represented by the following formula (I): 1Type: ApplicationFiled: March 1, 2001Publication date: December 27, 2001Inventors: Etsuo Ohshima, Koji Yanagawa, Haruhiko Manabe, Ichiro Miki, Yoshiaki Masuda
-
Patent number: 5319085Abstract: Quinoline derivatives represented by formula (I): ##STR1## wherein A-B-D represents --C(COO--Y).dbd.CH--C(OR).dbd. (wherein Y represents 8-methyl-8-azabicyclo[3.2.1]oct-3-yl group and R represents alkyl) or --C(OH).dbd.C(COX--Y)--CH.dbd. (wherein X represents --O-- or --NH--; and Y has the same meaning as described above), or a pharmaceutically acceptable salt thereof, possess potent 5HT.sub.3 antagonizing activity and are useful as antiemetic agents.Type: GrantFiled: April 16, 1993Date of Patent: June 7, 1994Assignee: Kyowa Hakko Kogyo Co., Ltd.Inventors: Fumio Suzuki, Hiroaki Hayashi, Yoshikazu Miwa, Takeshi Kuroda, Akio Ishii, Shunji Ichikawa, Ichiro Miki, Katsuichi Shuto